All Stories

  1. Rasamsonia argillacea species complex myocarditis in a patient with chronic granulomatous disease
  2. Right Ventricular Function and Prognosis in Patients with Low-Flow, Low-Gradient Severe Aortic Stenosis
  3. A pathoanatomic approach to the management of mitral regurgitation
  4. Diastolic function improvement is associated with favourable outcomes in patients with acute non-ischaemic cardiomyopathy: insights from the multicentre IMAC-2 trial
  5. Watchful waiting in aortic stenosis: are we ready for individualizing the risk assessment?
  6. TCT-662 Prognostic Importance Of Pulmonary Hypertension Etiology By Invasive Hemodynamics In Patients With Severe Aortic Stenosis
  7. Acute cocaine myocarditis: a word of caution
  8. The association of global longitudinal and global circumferential strain with ejection fraction in patients with aortic stenosis and increased left ventricular mass: a feature tracking CMR study
  9. Meta-analysis of coronary computed tomography angiography versus standard of care strategy for the evaluation of low risk chest pain: Are randomized controlled trials and cohort studies showing the same evidence?
  10. Is there a role for diastolic function assessment in era of delayed enhancement cardiac magnetic resonance imaging?
  11. HEMODYNAMIC ASSESSMENT OF LOW GRADIENT AORTIC STENOSIS WITH PRESERVED EJECTION FRACTION
  12. Global left ventricular remodeling, extent of inferior wall infarct, and mitral valve geometry are important predictors of mitral regurgitation severity than total infarct size in advanced ischemic cardiomyopathy
  13. From Headache to Heartache
  14. Feature tracking measurement of dyssynchrony from cardiovascular magnetic resonance cine acquisitions: comparison with echocardiographic speckle tracking
  15. Role of Cross-Sectional Imaging for Structural Heart Disease Interventions
  16. An Unexpected Fate
  17. BARIATRIC SURGERY IS ASSOCIATED WITH LEFT VENTRICULAR EJECTION FRACTION IMPROVEMENT IN OBESE PATIENTS WITH SYSTOLIC HEART FAILURE
  18. IMPACT OF MITRAL REGURGITATION ON MORTALITY IN PATIENTS WITH SEVERE ISCHEMIC CARDIOMYOPATHY AND SUBSEQUENT INCOMPLETE REVASCULARIZATION IN THE SETTING OF JEOPARDIZED MYOCARDIUM
  19. Two-Dimensional Longitudinal Strain Assessment in the Presence of Myocardial Contrast Agents Is Only Feasible with Speckle-Tracking after Microbubble Destruction
  20. Association of Epicardial Fat, Hypertension, Subclinical Coronary Artery Disease, and Metabolic Syndrome With Left Ventricular Diastolic Dysfunction
  21. Role of Echocardiography in Percutaneous Mitral Valve Interventions
  22. Diversity of Mitral Valve Abnormalities in Obstructive Hypertrophic Cardiomyopathy
  23. A New Diagnosis of Severe Aortic Coarctation Presenting in Adult Life
  24. Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients
  25. Aortic Stiffness
  26. REGIONAL LV AND RV FREE WALL LONGITUDINAL STRAIN BY SPECKLE TRACKING IS REDUCED IN PATIENTS WITH CONSTRICTIVE PERICARDITIS: AN MRI CORRELATION STUDY
  27. Assessing Risk and Predicting Outcomes in Coronary Artery Disease: Physiology, Anatomy, or Biology?
  28. Role of multimodality imaging in ischemic and non-ischemic cardiomyopathy
  29. Isolated Right Ventricular Infarct Presenting as Ventricular Fibrillation Arrest and Confirmed by Delayed-Enhancement Cardiac MRI
  30. VALUE OF FAMILY HISTORY OF PREMATURE CORONARY ARTERY DISEASE AS A PREDICTOR OF OBSTRUCTIVE CORONARY ARTERY DISEASE ON CORONARY CT ANGIOGRAPHY, THE ACIC REGISTRY
  31. IS STRESS MYOCARDIAL PERFUSION IMAGING WITH REGADENOSON, A NEW PHARMACOLOGIC STRESS AGENT, SAFE IN ORTHOTOPIC HEART TRANSPLANT PATIENTS? FIRST REPORT OF REGADENOSON, A SELECTIVE A2A RECEPTOR AGONIST IN THE HEART TRANSPLANT POPULATION
  32. EVEREST study: Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan
  33. The Relationship Between Spontaneous Echocontrast, Transesophageal Echocardiographic Parameters, and Blood Hemoglobin Levels
  34. Renal Response After High-Dose Melphalan and Stem Cell Transplantation Is a Favorable Marker in Patients With Primary Systemic Amyloidosis
  35. Effects of l-arginine-enriched total enteral nutrition on body weight gain, tumor growth, and in vivo concentrations of blood and tissue metabolites in rats inoculated with Walker tumor in the kidney
  36. Modelo de tumor experimental em rim de ratos